{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:02:57Z","timestamp":1787022177109,"version":"build-2736575974"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Matriglycan of alpha dystroglycan (\u03b1-DG) serves as a receptor for extracellular matrix proteins. Hypoglycosylation of \u03b1-DG underlies specific types of muscular dystrophy, dystroglycanopathy. Fukutin Related Protein (\n                    <jats:italic>FKRP<\/jats:italic>\n                    ) gene encodes a glycosyltransferase that adds ribitol-5-phosphate to the core glycan of \u03b1-DG and enables the synthesis of matriglycan. Mutations in the\n                    <jats:italic>FKRP<\/jats:italic>\n                    gene are a common cause of dystroglycanopathies. Ribitol is able to restore matriglycan in diseased muscles with FKRP mutations, but this effect relies on partial function of mutant FKRPs. Different mutations affect FKRP function differently, which could affect the efficiency of ribitol treatment. Here we examined the long-term effect of ribitol in mice with\n                    <jats:italic>\n                      FKRP\n                      <jats:italic>C826A (<\/jats:italic>\n                    <\/jats:italic>\n                    L276I) mutation, the most common genotype in patient population of LGMD2I\/R9. Oral administration of ribitol significantly enhances expression of matriglycan in both cardiac and skeletal muscles up to 40% of normal muscle levels. Importantly, matriglycan is homogeneously expressed in almost all muscle fibers with similar levels especially in cardiac muscle. Consistently, muscle degeneration and regeneration are greatly attenuated with reduced central nucleation and fibrosis especially in the diaphragm. This is associated with improvements in muscle functions, although the diseased mice only show limited deficiency when compared to wild type C57 mice. The higher level of restoration in matriglycan in L276I mice than in P448L mice is consistent with the hypothesis that therapeutic potential of ribitol treatment may depend on the remaining function of mutant FKRPs. These results support clinical trials of ribitol to the majority of patients with FKRP mutations.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0325239","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T17:27:16Z","timestamp":1755710836000},"page":"e0325239","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ribitol treatment rescues dystroglycanopathy mice with common L276I mutation"],"prefix":"10.1371","volume":"20","author":[{"given":"Bo","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Juan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Drains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapana","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Blaeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessalyn","family":"Killilee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6969-0121","authenticated-orcid":true,"given":"Qi Long","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"7","key":"pone.0325239.ref001","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/glycob\/cwv021","article-title":"Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane","volume":"25","author":"T Yoshida-Moriguchi","year":"2015","journal-title":"Glycobiology"},{"issue":"9","key":"pone.0325239.ref002","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/glycob\/cwx062","article-title":"Recent advancements in understanding mammalian O-mannosylation","volume":"27","author":"MO Sheikh","year":"2017","journal-title":"Glycobiology"},{"issue":"9","key":"pone.0325239.ref003","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","article-title":"Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy","volume":"14","author":"M Kanagawa","year":"2016","journal-title":"Cell Rep"},{"key":"pone.0325239.ref004","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14473","article-title":"The functional O-mannose glycan on \u03b1-dystroglycan contains a phospho-ribitol primed for matriglycan addition","volume":"5","author":"JL Praissman","year":"2016","journal-title":"Elife"},{"key":"pone.0325239.ref005","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1038\/ncomms11534","article-title":"ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto \u03b1-dystroglycan","volume":"7","author":"I Gerin","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"pone.0325239.ref006","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1073\/pnas.0307228101","article-title":"Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity","volume":"101","author":"H Manya","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6148","key":"pone.0325239.ref007","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1239951","article-title":"SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function","volume":"341","author":"T Yoshida-Moriguchi","year":"2013","journal-title":"Science"},{"issue":"3","key":"pone.0325239.ref008","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ajhg.2012.07.009","article-title":"Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome","volume":"91","author":"MC Manzini","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"14","key":"pone.0325239.ref009","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1074\/jbc.M310614200","article-title":"A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAc","volume":"279","author":"T Hiruma","year":"2004","journal-title":"J Biol Chem"},{"issue":"47","key":"pone.0325239.ref010","doi-asserted-by":"crossref","first-page":"24618","DOI":"10.1074\/jbc.M116.751917","article-title":"The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol \u03b21,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan","volume":"291","author":"H Manya","year":"2016","journal-title":"J Biol Chem"},{"key":"pone.0325239.ref011","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03941","article-title":"The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated alpha-dystroglycan functional glycosylation.","volume":"3","author":"T Willer","year":"2014","journal-title":"eLife"},{"issue":"6064","key":"pone.0325239.ref012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1214115","article-title":"Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE","volume":"335","author":"K Inamori","year":"2012","journal-title":"Science"},{"issue":"6","key":"pone.0325239.ref013","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/324412","article-title":"Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan","volume":"69","author":"M Brockington","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5","key":"pone.0325239.ref014","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2003.013870","article-title":"Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome","volume":"41","author":"D Beltran-Valero de Bernab\u00e9","year":"2004","journal-title":"J Med Genet"},{"issue":"25","key":"pone.0325239.ref015","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/hmg\/10.25.2851","article-title":"Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C","volume":"10","author":"M Brockington","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"2","key":"pone.0325239.ref016","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0002-9440(10)63160-4","article-title":"Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies","volume":"164","author":"SC Brown","year":"2004","journal-title":"Am J Pathol"},{"issue":"12","key":"pone.0325239.ref017","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.chembiol.2015.10.014","article-title":"Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation","volume":"22","author":"M Riemersma","year":"2015","journal-title":"Chem Biol"},{"key":"pone.0325239.ref018","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.omtn.2018.02.008","article-title":"Overexpression of Mutant FKRP Restores Functional Glycosylation and Improves Dystrophic Phenotype in FKRP Mutant Mice","volume":"11","author":"JD Tucker","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"pone.0325239.ref019","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.ajpath.2015.03.017","article-title":"Restoration of Functional Glycosylation of \u03b1-Dystroglycan in FKRP Mutant Mice Is Associated with Muscle Regeneration","volume":"185","author":"H Awano","year":"2015","journal-title":"Am J Pathol"},{"issue":"4","key":"pone.0325239.ref020","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/mus.25378","article-title":"Expression of glycosylated \u03b1-dystroglycan in newborn skeletal and cardiac muscles of fukutin related protein (FKRP) mutant mice","volume":"55","author":"E Keramaris","year":"2017","journal-title":"Muscle Nerve"},{"issue":"1","key":"pone.0325239.ref021","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1038\/s41467-018-05990-z","article-title":"Ribitol restores functionally glycosylated \u03b1-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice","volume":"9","author":"MP Cataldi","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"pone.0325239.ref022","article-title":"Ribitol dose-dependently enhances matriglycan expression and improves muscle function with prolonged life span in limb girdle muscular dystrophy 2I mouse model","volume":"17","author":"B Wu","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"pone.0325239.ref023","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00439-013-1302-7","article-title":"Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes","volume":"132","author":"A Blaeser","year":"2013","journal-title":"Hum Genet"},{"issue":"20","key":"pone.0325239.ref024","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1093\/hmg\/ddq314","article-title":"Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies","volume":"19","author":"YM Chan","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"2","key":"pone.0325239.ref025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JND-230205","article-title":"Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of Interpretation","volume":"11","author":"QL Lu","year":"2024","journal-title":"J Neuromuscul Dis"},{"issue":"11","key":"pone.0325239.ref026","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/mt.2014.141","article-title":"Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery","volume":"22","author":"C Qiao","year":"2014","journal-title":"Mol Ther"},{"issue":"4","key":"pone.0325239.ref027","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"JM Ervasti","year":"1993","journal-title":"J Cell Biol"},{"issue":"11","key":"pone.0325239.ref028","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10038-006-0056-7","article-title":"The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesis","volume":"51","author":"M Kanagawa","year":"2006","journal-title":"J Hum Genet"},{"key":"pone.0325239.ref029","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.omtm.2017.02.002","article-title":"Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene","volume":"5","author":"CH Vannoy","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"10","key":"pone.0325239.ref030","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/hmg\/3.10.1725","article-title":"Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform","volume":"3","author":"JA Rafael","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"8","key":"pone.0325239.ref031","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/4.8.1251","article-title":"Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice","volume":"4","author":"SF Phelps","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"5","key":"pone.0325239.ref032","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ana.20283","article-title":"Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I","volume":"56","author":"M Poppe","year":"2004","journal-title":"Ann Neurol"},{"issue":"9","key":"pone.0325239.ref033","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/eurjhf\/hft057","article-title":"Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I","volume":"15","author":"KG Hollingsworth","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"pone.0325239.ref034","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.nmd.2008.06.365","article-title":"Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study","volume":"18","author":"K Wahbi","year":"2008","journal-title":"Neuromuscul Disord"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T17:27:21Z","timestamp":1755710841000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325239"}},"subtitle":[],"editor":[{"given":"Mohd Akbar","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325239","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}